Cancer stem cells (CSCs) represent both a key driving force and therapeutic target of
tumoral carcinogenesis, tumor evolution, progression, and recurrence. CSC-guided tumor …

Nanomaterials have great potential for the prevention and treatment of cancer. Circulating
tumor cells (CTCs) are cancer cells of solid tumor origin entering the peripheral blood after …

Liquid biopsy allows for the quick and noninvasive detection of tumor-associated
components. Various liquid biopsy components, which include circulating tumor cells, tumor …

Circulating tumor cells (CTCs) are cancer cells that shed from a primary tumor and circulate
in the bloodstream. As a form of “tumor liquid biopsy”, CTCs provide important information …

Liquid biopsy for determining the presence of cancer and the underlying tissue of origin is
crucial to overcome the limitations of existing tissue biopsy and imaging-based techniques …

Liquid biopsy enables noninvasive and dynamic analysis of molecular or cellular
biomarkers, and therefore holds great potential for the diagnosis, prognosis, monitoring of …

Cancer heterogeneity plays a vital part in cancer resistance and metastasis. To provide a
reliable approach to exert a therapy action and evaluate its efficiency in heterogeneous …

In article number 1805344, Ling Zhu, Chen Wang, Yanlian Yang, and co-workers
summarize recent progress in nanomaterials, nanostructures, nanodevices, and …

Although considerable efforts have been conducted to diagnose, improve, and treat cancer
in the past few decades, existing therapeutic options are insufficient, as mortality and …

Emerging evidence suggests that multiple tumor types are sustained by a small population
of transformed stem-like cells that have the ability to both self-renew and give rise to non …